If you want to Print any book or your desire book is not available on our website, Just whatsapp or call us at 0333-144-88-88
Drug Development for Rare Diseases (Chapman & Hall/CRC Biostatistics Series)
Drug Development for Rare Diseases (Chapman & Hall/CRC Biostatistics Series)

400.00900.00

A disease is defined as rare if the prevalence is fewer than 200,000 in the United States. It is estimated that there are more than 7,000 rare diseases, which collectively affect 30 million Americans or 10% of the US population. This diverse and complex disease area poses challenges for patients, caregivers, regulators, drug developers, and other stakeholders. This book is proposed

to give an overview of the common issues facing rare disease drug developers, summarize challenges specific to clinical development in small populations, discuss drug development strategies in the evolving regulatory environment, explain generation and utilization of different data and evidence

inside and beyond clinical trials, and use recent examples to demonstrate these challenges and the development strategies that respond to the challenges.

Key Features:

• Rare disease.

• Drug development.

• Innovative clinical trial design.

• Regulatory approval.

• Real-world evidence.

Buy online medical books at (Books Delivery) for home delivery and Cash on delivery to all over Pakistan. All kind of medical books are available.

 

Share :

Share on facebook
Share on twitter
Share on linkedin
Share on tumblr

Description

Drug Development for Rare Diseases (Chapman & Hall/CRC Biostatistics Series)

By Bo Yang (Editor), Yang Song (Editor), Yijie Zhou (Editor)

Key Features:

  • Rare Diseases: Explores the prevalence and complexity of rare diseases, which affect 30 million Americans (10% of the US population) and pose unique challenges for treatment.
  • Drug Development: Discusses the specific challenges faced by drug developers working on rare diseases and strategies for overcoming them.
  • Innovative Clinical Trial Design: Focuses on innovative approaches to clinical trials for small patient populations, addressing the difficulties in recruitment and data collection.
  • Regulatory Approval: Examines the evolving regulatory environment and strategies for obtaining approval for treatments targeting rare diseases.
  • Real-World Evidence: Highlights the importance of real-world data in supplementing clinical trials and demonstrating the effectiveness of treatments beyond controlled settings.

 

Drug Development for Rare Diseases (Chapman & Hall/CRC Biostatistics Series) available at Book delivery.com for home delivery and cash on delivery all over Pakistan. You can contact for all kind of Medical Books.

Additional information

Print Quailty

Black & White Print, Colour Matt Finshed

About The Author

"My enthusiasm for writing never stops" - John Doe

Nullam venenatis neque dis viverra hendrerit faucibus ornare feugiat urna. Tristique sollicitudin penatibus velit a class auctor himenaeos. Mollis semper luctus sit efficitur nam vitae feugiat enim tortor. Tortor montes integer cras massa donec ex ligula. Aliquet fringilla tellus mattis augue nam dui justo aliquam quisque suspendisse maximus. Pede velit ut dapibus suspendisse vivamus pulvinar nostra morbi curae potenti netus.

Promotion

Flat 50% OFF, Hurry up before the stock ends

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Testimonials

Customer Reviews

Porttitor eleifend facilisi euismod litora etiam consectetur. Vivamus platea quisque mauris si blandit diam id a primis himenaeos. Natoque vulputate duis nec mauris tristique integer mi. Pharetra libero quam morbi lectus lacinia. Pharetra lacus ut litora mattis cras arcu tortor bibendum vitae.